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Abstract 24	  
   25	  
Cytomegalovirus’s (CMV’s) unique ability to drive the expansion of virus-specific T-cell 26	  
populations over the course of a lifelong, persistent infection has generated interest in the virus 27	  
as a potential vaccine strategy. When designing CMV-based vaccine vectors to direct immune 28	  
responses against HIV or tumor antigens, it becomes important to understand how and why 29	  
certain CMV-specific populations are chosen to inflate over time. To investigate this, we 30	  
designed recombinant murine cytomegaloviruses (MCMV) encoding a SIINFEKL-eGFP fusion 31	  
protein under the control of endogenous immediate early promoters. When mice were infected 32	  
with these viruses, T cells specific for the SIINFEKL epitope inflated and profoundly dominated 33	  
T cells specific for non-recombinant (i.e. MCMV-derived) antigens. Moreover, when the virus 34	  
encoded SIINFEKL, T cells specific for non-recombinant antigens displayed a phenotype 35	  
indicative of less frequent exposure to antigen. The immunodominance of SIINFEKL-specific T 36	  
cells could not be altered by decreasing the number of SIINFEKL-specific cells available to 37	  
respond, or by increasing the number of cells specific for endogenous MCMV antigens. In 38	  
contrast, coinfection with viruses expressing and lacking SIINFEKL enabled co-inflation of T 39	  
cells specific for both SIINFEKL and non-recombinant antigens. Because coinfection allows 40	  
presentation of SIINFEKL and MCMV-derived antigens by different cells within the same 41	  
animal, these data reveal that competition for, or availability of, antigen at the level of the 42	  
antigen presenting cell determines the composition of the inflationary response to MCMV. 43	  
SIINFEKL’s strong affinity for H2-Kb, and its early and abundant expression, may provide this 44	  
epitope’s competitive advantage.    45	  
 46	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Introduction 47	  
 48	  
Cytomegalovirus (CMV) establishes an asymptomatic latent or persistent infection, which is 49	  
characterized by the lifelong accumulation of a large number of virus-specific T cells.  This 50	  
process is termed memory inflation, and has led to the exploration of CMV as a vaccine vector 51	  
for HIV and for tumor antigens, with significant initial success in the SIV model (1, 2). The fact 52	  
that memory inflation occurs after infection with a single-cycle CMV (3) indicates that CMV-53	  
based vaccines may be safely used even in immunosuppressed cancer patients, further increasing 54	  
the appeal of this approach.  The vaccine potential of this virus has elevated the importance of 55	  
understanding how inflationary CMV-specific responses are selected and maintained during 56	  
infection.   57	  
  58	  
C57BL/6 mice mount a response to at least 20 viral antigens during acute infection with murine 59	  
CMV (MCMV) (4).   Most of these responses, including those to the immunodominant M45 60	  
antigen, then decline precipitously and leave small central memory (TCM) populations.  In 61	  
contrast, memory inflation is dominated by only three responses:  those to M38, m139 and IE3, 62	  
all of which are subdominant to M45 during acute infection (5).  These same three epitopes 63	  
display memory inflation after infection with the single cycle ΔgL-MCMV  (3), which implies 64	  
that non-productively infected cells harboring the viral genome can drive memory inflation.  65	  
 66	  
We presume that ongoing presentation of viral epitopes must be involved in memory inflation. 67	  
We have shown that memory inflation is sustained by repeated production of short-lived 68	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effectors derived from a pool of memory cells established early in infection (6). However, the 69	  
reason that inflationary responses focus on just a few antigens is not well understood.  70	  
 71	  
MCMV has a highly ordered sequence of lytic cycle gene expression, which starts with the 72	  
transcription of Immediate Early (IE) genes and is followed by the synthesis of Early (E) and 73	  
then Late (L) gene products. However, latent MCMV infection in the lungs and liver is 74	  
characterized by sporadic expression of IE genes without evidence of E or L gene expression (7, 75	  
8).  This is thought to be abortive reactivation, in which the virus initiates the standard lytic gene 76	  
cascade, but gene expression is aborted at the IE stage (9). This scenario predicts that IE gene 77	  
products would be the most abundant during latent infection and thus immunodominant, which is 78	  
at least partly the case: IE3 becomes progressively more immunodominant over time in B6 mice, 79	  
and pp89 (IE1)-specific responses inflate somewhat more than those specific for the E antigen 80	  
m164 in BALB/c mice. Furthermore, recombinant epitopes expressed behind IE promoters 81	  
provoke inflationary responses (10). However, M38 and m139, both E antigens, also provoke 82	  
immunodominant inflationary responses in B6 mice, as does m164 in BALB/c mice (5). 83	  
Likewise in humans, T cells target epitopes expressed with IE, E and L kinetics (11) and cells 84	  
specific for the L gene product pp65 are frequently immunodominant (12-14). The viral gene 85	  
expression program that drives these diverse responses is not yet clear.   86	  
 87	  
Our data suggest that viral gene expression, and not productive replication, is sufficient to 88	  
promote inflation of T cells specific for E gene products. This is evidenced by the ability of a 89	  
single cycle ΔgL-MCMV to stimulate inflation of T cells specific for the E genes M38, m139 90	  
and m164 (3). Abortive reactivation may sometimes proceed to expression of E genes, as 91	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suggested by Simon et. al. (9). An alternate possibility is that a completely different gene 92	  
expression program occurs in some infected cells. Indeed, in the rat CMV heart transplant model, 93	  
expression of a subset of E genes without production of infectious virus has been described (15).  94	  
It is interesting that this “persistent” pattern of gene expression involved very little IE gene 95	  
expression.  Similarly, expression of some viral genes in the absence of IE gene expression is 96	  
reported in monocytes latently infected with human CMV (16).  Hence, inflationary responses to 97	  
E epitopes may be driven by different cells harboring a different program of gene expression 98	  
than those that drive the IE responses.  99	  
 100	  
There is also some evidence that T cells can influence the pattern of immunodominance during 101	  
memory inflation. Indeed, Holtappels et. al. (17) described a “conditional” immunodominant 102	  
response specific for the viral m145 gene product in Balb/c mice, which appeared when the 103	  
immunodominant m164- and IE1-derived epitopes were deleted. In line with this, Simon et. al. 104	  
have suggested that T cells directly limit the cascade of viral gene expression (9). Thus, 105	  
immunodominant T cell responses may restrict other epitopes from being produced. Inflationary 106	  
T cell responses of particularly high avidity, either due to expression of high affinity T cell 107	  
receptors (TCRs), or to abundant antigen expression, might enforce a selective advantage by 108	  
suppressing expression of additional epitopes.   109	  
 110	  
Here, we describe memory inflation in response to recombinant MCMVs that encode a 111	  
SIINFEKL-GFP fusion protein under immediate early control. Not only did SIINFEKL promote 112	  
memory inflation, it became the sole inflationary epitope during chronic infection.  We used this 113	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model to explore the determinants of immunodominance in the inflationary T cell response to 114	  
MCMV.    115	  
 116	  
 117	  
 118	  
 119	  
 120	  
 121	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 123	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 125	  
 126	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 129	  
 130	  
 131	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Materials and Methods 137	  
 138	  
Mice 139	  
C57BL/6 mice were purchased from The Jackson Laboratory. B6.SJL-CD45.1 congenic 140	  
(B6.SJL-Ptprca Pepcb/BoyJ) mice were also purchased from The Jackson Laboratory and bred to 141	  
C57BL/6 mice in house to generate CD45.1/CD45.2 F1 mice as recipients for adoptive transfer 142	  
experiments. OVA-Tg mice were bred from the B6.FVB-Tg(MMTV-neu/OT-I/OT-II)CBnel 143	  
Tg(Trp53R172H)8512Jmr/J strain to express the Erbb2/HER-2/neu oncogene tagged with 144	  
ovalbumin epitopes recognized by the OT-I and OT-II , but not the Trp53 gene (18). Breeders of 145	  
this strain were obtained from The Jackson Laboratory. Mice were between the ages of 6 and 16 146	  
weeks upon infection. All studies were approved by the Institutional Biosafety Committee and 147	  
the Institutional Animal Care and Use Committee at Oregon Health and Sciences University.  148	  
 149	  
Virus Strains and Infections 150	  
Mice were infected i.p. with 2 x 105 PFU of virus, except in coinfection experiments, where mice 151	  
were infected with 1 x 105 PFU of each virus used.  Virus labeled MCMV-WT BAC was of the 152	  
strain MW97.01, which is derived from a bacterial artificial chromosome of the Smith strain 153	  
(19). MCMV-GFP-SL8 and MCMV-GFP-MSL8 were generated on the MW97.01 backbone. In 154	  
both recombinant viruses, the SIINFEKL peptide plus 7 N-terminal amino acids from ovalbumin 155	  
(SGLEQLESIINFEKL, to facilitate normal peptide excision, (20)) were fused to the C-terminal 156	  
end of eGFP. In the case of MCMV-GFP-SL8, this fusion construct was targeted to replace the 157	  
m128 (IE2) gene, under the control of the IE2 promoter, using established techniques (21). In the 158	  
case of MCMV-GFP-MSL8, the eGFP-SL8 fusion construct was encoded with the Major 159	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Immediate Early promoter (MIEP) of HCMV and targeted to replace exon 3 of the m128 gene in 160	  
MCMV. Stocks of these viruses were produced from murine embryonic fibroblasts and titered by 161	  
plaque assay on Balb3T3s without centrifugal enhancement.  162	  
 163	  
To produce the  ΔgL viruses, an ampicillin gene fragment was inserted into the M115 (gL) gene 164	  
of the MCMV-WT BAC (strain MW97.01, (22)) using homologous recombination. Stocks of 165	  
this virus were produced on gL-3T3 cells, which provide gL in trans (3), and titered by plaque 166	  
assay on gL-3T3s without centrifugal enhancement. The individual virus stock used in figure 3 167	  
was checked for reversion by infecting murine embryonic fibroblasts, a non complementing cell 168	  
line, then passaging and monitoring these infected cells for 30 days. The growth of cells not 169	  
infected by the initial inoculum confirmed the inability of the this gL-deficient virus to spread 170	  
from cell to cell.   171	  
 172	  
Intracellular Cytokine Staining and FACS Analysis 173	  
For measurement of intracellular IFN-γ, peripheral blood was collected at the indicated time 174	  
points. Red blood cells were lysed with 3 ml of lysis buffer (150 mM NH4Cl, 10 mM NaHCO3) 175	  
and the remaining cells were incubated for 5-6 hrs at 37oC in the presence of 10 µM of the 176	  
indicated peptide and brefeldin A (GolgiPlug; BD Pharmingen).  Surface staining was done 177	  
overnight at 4°C, and cells were fixed and permeabilized for intracellular cytokine staining with 178	  
Cytofix/Cytoperm (BD Pharmingen). The following fluorescently conjugated antibodies were 179	  
used (CD8α [clone 53-6.7], CD27 [clone LG.7F9], CD3 [clone 145-2C11], CD127[clone 180	  
A7R34], KLRG1 [clone 2F1], IFN-γ [clone XMG1.2]), and all purchased from either BD 181	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Biosciences, eBioscience, or BioLegend. Samples were acquired on an LSR II or a FACSCalibur 182	  
(both BD) and analyzed with FLowJo software (Tree Star).  183	  
 184	  
Adoptive Transfers 185	  
Splenocytes from congenic mice infected for 7 days with MCMV-WT BAC were harvested, 186	  
passed through a 70 µm cell strainer, washed twice with T cell media (RPMI 1640 with L-187	  
glutamine + 10% FBS + 1% penicillin/streptomycin + 5 x 10-5 M β-mercaptoethanol) and 188	  
resuspended in PBS at 5 x 108 cells/ml.  100µl of this unfractionated splenocyte suspension was 189	  
injected into each congenic recipient via the retro-orbital route. These mice were infected with 190	  
either MCMV-GFP-SL8 or MCMV WT-BAC the following day.  191	  
 192	  
RMA-S Peptide Binding and Stabilization Assays 193	  
For binding assays, TAP-deficient RMA-S cells were plated at 1x105 cells/well in 96-well plates 194	  
and cultured for 16 h at 25 °C in T cell media buffered with 25mM HEPES. The cells were then 195	  
washed with T cell media, incubated with different concentrations of the indicated peptides at 196	  
25 °C for 2 hours, and then incubated for an additional 2 hours at 37 °C. After this incubation, 197	  
cells were washed once and stained on ice for 1 hour with PE-conjugated Y3 mAb, which binds 198	  
to the class I MHC H-2Kb. The cells were then washed twice with PBS, fixed with BD Fix/Perm 199	  
solution, and analyzed on a BD FACSCalibur.  200	  
 201	  
Quantitative Real-time PCR 202	  
1 x 106 murine embryonic fibroblasts were infected with WT MCMV or MCMV-GFP-SL8 at a 203	  
multiplicity of infection of 10. Cells were harvested at 0, 1, 2, 3, 4, 8, 18, and 24 hours post 204	  
	   10	  
infection, and RNA was extracted using the Qiagen RNeasy Mini Kit (Qiagen). On-column 205	  
DNAse treatment was performed as described in the Qiagen protocol. cDNA was generated 206	  
using the Invitrogen SuperScript III First-Strand Synthesis SuperMix. A portion of each sample 207	  
was treated similarly, but without the addition of reverse transcriptase to ensure that there was no 208	  
DNA contamination. cDNA was then stored at -20 °C. Quantitative PCR was performed using 209	  
Platinum SYBR green qPCR SuperMix UGD with ROX, using the primers at a concentration of 210	  
250nM. The samples were run on an ABI PRISM 7700 Sequence Detection System. Relative 211	  
gene expression was determined by normalizing each gene to β-actin, and comparing the gene 212	  
expression relative to cells at 0 h. The calculations were made following the method described in 213	  
the User Bulletin Number 2: ABI Prism 7700 sequence detection system; subject, relative 214	  
quanititation of gene expression (Applied Biosystems). Primer sequences follow.  SL8 F: 215	  
ACGTAAACGGCCACAAGTTC, SL8 R: TGAACTTCAGGGTCAGCTTG, IE3 F: 216	  
GATTCAACCCGCCTGTTATG, IE3 R: GATAATTCAGGCAGCCAACC, M38 217	  
F:TCGATATTGAGCTGCTTGA, M38 R: CCCAGCCTGCAAGACTTC, m139 F: 218	  
GCGCTCTGTGACAGAGTTT, m139 R: ACGAGCAACAACATGGAA.  219	  
 220	  
 221	  
 222	  
 223	  
 224	  
 225	  
 226	  
 227	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Results  228	  
SIINFEKL-specific CD8+ T cells dominate memory inflation after infection with MCMV-GFP-229	  
SL8.  230	  
 231	  
We generated a recombinant strain of MCMV expressing a GFP-SIINFEKL fusion construct 232	  
under the control of the endogenous MCMV IE2 promoter (Turula et. al., manuscript submitted).  233	  
After infection with this virus (MCMV-GFP-SL8), the SIINFEKL-specific CD8 T cell responses 234	  
in B6 mice steadily inflated over time, becoming the dominant inflationary T cell population in 235	  
these animals at chronic time points (Figures 1A and B). We also generated a virus in which the 236	  
GFP-SIINFEKL fusion construct is under control of the HCMV Major Immediate Early 237	  
promoter (MCMV-GFP-MSL8), resulting in approximately 10-20 fold greater GFP fluorescence 238	  
after in vitro infection (not shown). SIINFEKL-specific T-cells dominated the inflationary 239	  
response in mice infected with this virus as well (data not shown). Responses to IE3- and M38-240	  
derived peptides were barely detectable in these animals, whereas T cells specific for these 241	  
epitopes each comprised approximately 5% of the CD8 T-cell compartment in mice infected 242	  
with WT MCMV (Figure 1A and (5)). Proportional changes in T-cell numbers cannot explain 243	  
the disappearance of IE3 and M38 responses, as M45-specific cell populations occupied the 244	  
same percentage of CD8+ T cells in mice infected with either virus.  Nor did frequencies of total 245	  
cells in the blood of these animals indicate a disproportionate increase in SIINFEKL-specific T-246	  
cell numbers relative to IE3- and M38-spcific T-cell numbers (not shown). Thus, the presence of 247	  
the SIINFEKL epitope and the resulting T cell response suppressed inflation of IE3- and M38-248	  
specific T cells, despite evidence that M38-specific T cells were successfully primed during 249	  
acute infection.    250	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 251	  
SIINFEKL responses dominate memory inflation when SIINFEKL is expressed in a single cycle 252	  
MCMV. 253	  
 254	  
To determine whether the profound immunodominance of SIINFEKL would also occur in a 255	  
single cycle MCMV, we produced a version of MCMV-SL8-GFP lacking gL, a glycoprotein 256	  
necessary for cell entry and spread. The ΔgL-SL8 virus was confirmed to be spread-deficient as 257	  
described in the methods, but still induced SIINFEKL-specific T cells to inflate and become 258	  
dominant (Figure 1C), indicating that productive infection is not needed for the 259	  
immunodominance of this response.    260	  
 261	  
Phenotype of cells specific for inflationary epitopes after infection with MCMV-GFP-SL8 262	  
 263	  
Inflationary CD8+ T cells express KLRG1, and have low levels of the IL-7 receptor (CD127) 264	  
and the costimulatory molecule CD27 (6). This terminally differentiated effector phenotype is 265	  
consistent with recent or repeated antigen exposure. Conversely, T cells comprising the memory 266	  
response to non-inflationary epitopes M45 and M57 exhibit a memory phenotype (KLRG1-, 267	  
CD27+ and CD127+), which suggests that they are rarely exposed to antigen after the acute 268	  
phase of infection. Because responses to M38 and IE3 contract sharply after acute MCMV-GFP-269	  
SL8 infection, we wondered whether they would also develop a memory phenotype.  270	  
 271	  
Figure 2 shows that SIINFEKL-specific CD8’s at week 18 post infection exhibit the classic 272	  
phenotype of inflationary MCMV T cells, with upregulated expression of KLRG1 and 273	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downregulation of CD27 and CD127. In contrast, T cells specific for M45 mostly lacked KLRG1 274	  
and retained expression of CD127 and CD27, although some cells were KLRG1+. This is similar 275	  
to their phenotype in WT infection. Strikingly, the small M38-specific population found in 276	  
MCMV-GFP-SL8 infected mice had a similar phenotype to the M45-specific cells: most cells 277	  
lacked KLRG1, and retained CD27 and high levels of CD127. IE3-specific cells were so 278	  
infrequent that an accurate assessment of their phenotype was impossible. These results suggest 279	  
that SIINFEKL-specific cells have seen antigen recently or repeatedly and that M45- and M38-280	  
specific cells encounter antigen rarely.  281	  
 282	  
Altering the ratios of functional, epitope-specific cells available to respond to infection does not 283	  
influence the immunodominance of SIINFEKL-specific T cells. 284	  
 285	  
The precursor frequency of antigen-specific T cells - either naïve or memory - is a major 286	  
determinant of immunodominance during acute infections, and also affects proliferation and 287	  
memory CD8 T-cell lineage decisions (23). We wondered whether we could modify the 288	  
immunodominance of the SIINFEKL response during chronic infection by altering the ratios of 289	  
functional, epitope-specific CD8 T-cells prior to infection. We explored this possibility in three 290	  
ways.  291	  
 292	  
First, we used mice that express OVA as a self-antigen behind the Mouse Mammary Tumor 293	  
Virus promoter. When these mice were infected with MCMV-GFP-MSL8, the acute response to 294	  
SIINFEKL was approximately one third of that in WT mice (Figure 3A), consistent with a lower 295	  
number of SIINFEKL-specific precursors. Nevertheless, during chronic infection with either 296	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MCMV-GFP-MSL8 (not shown) or MCMV-GFP-SL8, the SIINFEKL response inflated at the 297	  
expense of the M38 and m139 responses (Figure 3A).  298	  
 299	  
Next, we reduced the number of naïve CD8+ T-cells capable of responding to SIINFEKL during 300	  
acute infection by intravenous injection of SIINFEKL peptide prior to infection. Intravenous 301	  
peptide provides a large amount of antigen (signal 1) in the absence of costimulation (signal 2), 302	  
resulting in anergy or deletion of cognate T cells (24-26). Mice were injected i.v. with 10µg of 303	  
SIINFEKL peptide on each of the 3 days prior to infection. SIINFEKL-specific T cells were not 304	  
detected by ICS or tetramer staining 7 days post-infection, indicating profound suppression and 305	  
probable deletion of SIINFEKL-specific cells, whereas T cells specific for MCMV epitopes were 306	  
primed normally (Figure 3B). However, by week 12, SIINFEKL responses had risen to the same 307	  
percentage of total CD8s as those of mice left untreated, and responses to IE3 and M38 were 308	  
barely detectable (Figure 3B).  309	  
 310	  
In a third experiment, we asked whether increasing the number of T cells available to respond to 311	  
IE3 and M38 would enable those responses to inflate after infection with the SIINFEKL-312	  
expressing virus.  Splenocytes from CD45.2+ donor mice that had been infected with WT 313	  
MCMV 7 days previously were adoptively transferred into CD45.1+CD45.2+ F1 naïve 314	  
recipients. These mice were then infected with MCMV-GFP-SL8.  A control group received 315	  
splenocytes from the same donors, but was infected with WT MCMV instead. Figure 3C shows 316	  
that the SIINFEKL-specific response still dominated memory inflation at the expense of the IE3 317	  
and M38 responses. This was not because the transferred cells were unable to proliferate, as the 318	  
donor cells expanded and contributed to inflation in WT-infected mice (Figure 3C). Thus, pre-319	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expanding T cells specific for MCMV epitopes were not able to override the profound 320	  
immunodominance of SIINFEKL-specific CD8 T cells in chronic infection.  321	  
 322	  
Together these results suggest that the frequency of epitope-specific cells available prior to 323	  
infection is not the most significant factor in determining the size of the SIINFEKL response 324	  
relative to other MCMV responses during chronic infection with MCMV-GFP-SL8.  325	  
 326	  
Competition for antigen shapes immunodominance during chronic MCMV infection 327	  
 328	  
Because precursor frequency did not explain SIINFEKL’s dominance during chronic infection, 329	  
we asked whether the phenomenon was the result of competition between T-cells at the level of 330	  
the APC. This phenomenon has been termed immunodomination (27). To test this, we co-331	  
infected mice with both WT MCMV and MCMV-GFP-SL8. Previous work has shown that co-332	  
infection with 2 viruses yields distinct foci of infection with each individual virus (28). Thus, in 333	  
our experiments, WT MCMV and MCMV-GFP-SL8 should largely infect different cells within 334	  
the same host and their epitopes should be presented to T-cells by different APCs. This 335	  
eliminates competition between T-cells of different specificities at the level of the APC. 336	  
 337	  
In mice receiving both viruses, responses to SIINFEKL and to the MCMV epitopes IE3 and M38 338	  
were co-dominant during chronic infection (Figure 4A). We interpreted this to mean that T cells 339	  
specific for endogenous MCMV gene products were able to inflate when these epitopes were not 340	  
presented by APCs also presenting SIINFEKL. However, a trivial explanation for this would be 341	  
that a much faster replicating WT virus would result in a greater abundance of MCMV epitopes 342	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in co-infected mice. Indeed, MCMV-SL8-GFP does grow with slightly delayed kinetics in vitro 343	  
(Turula et. al., manuscript submitted).  344	  
 345	  
To ensure that this was not the case, we repeated these co-infection experiments with a single-346	  
cycle virus, ΔgL-MCMV, in place of WT MCMV. Despite lacking gL, this virus can still 347	  
promote memory inflation during chronic infection (Figure 4B and (3)). Nevertheless, in mice 348	  
co-infected with MCMV-GFP-SL8 and ΔgL-MCMV, antigens from MCMV-GFP-SL8 would 349	  
clearly be more abundant. Figure 4B shows that at 18 weeks post infection, responses to IE3, 350	  
M38 and m139 were similar in co-infected mice and mice infected with ΔgL-MCMV alone. 351	  
These data indicate that the results in Figure 4A are not due to differing rates of viral replication. 352	  
We therefore conclude that competition at the level of the antigen presenting cell influences 353	  
inflation and immunodominance during MCMV infection.  354	  
 355	  
SIINFEKL is expressed earlier and has a higher MHC binding affinity than endogenous MCMV 356	  
epitopes 357	  
 358	  
The above data established that SIINFEKL is able to out-compete endogenous MCMV epitopes 359	  
to promote T-cell inflation when presented on the same APC. The mechanisms that cause the 360	  
immune system to narrowly focus T cell responses on a few immunodominant epitopes are not 361	  
completely understood. That being said, some factors are obviously important: peptides that are 362	  
more abundantly presented, either due to expression, processing, or binding affinity, are more 363	  
likely to be the focus of these responses (29, 30).  364	  
 365	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To compare the MHC binding affinity of SIINFEKL and the MCMV-derived inflationary 366	  
epitopes, all of which are presented by H-2Kb, we evaluated the ability of these peptides to 367	  
stabilize Kb on the surface of the TAP-deficient cell line RMA-S. Figure 5A shows that 368	  
SIINFEKL bound Kb most strongly, followed by M38 and m139, with IE3 binding with the 369	  
weakest affinity. Thus, a better ability to bind Kb would favor SIINFEKL presentation. 370	  
 371	  
Epitope presentation is also affected by the amount of parent protein available for degradation 372	  
and presentation. Because SIINFEKL dominated memory inflation after infection with the single 373	  
cycle ΔgL-SL8, we presume that cells harboring the latent viral genome, or their progeny, are 374	  
responsible for the antigen presentation that drives memory inflation. Since the identity of these 375	  
cells is unknown, it is not possible to definitively describe antigen synthesis and presentation at 376	  
this site. However, as described above, sporadic expression of IE genes in the absence of 377	  
detectable E or L genes has been described in latently infected lungs (7, 9). Preferential 378	  
expression of IE genes is the likely explanation for the immunodominance of IE-encoded 379	  
antigens during memory inflation. In MCMV-GFP-SL8, SIINFEKL is encoded behind the IE2 380	  
promoter and IE3 is driven by the Major Immediate Early promoter. To explore the timing of 381	  
expression of SIINFEKL, IE3, M38 and m139 during lytic cycle infection in vitro, we infected 382	  
murine embryonic fibroblasts with WT MCMV or MCMV-GFP-SL8, harvested RNA at various 383	  
time points after infection, and performed quantitative real time PCR. SIINFEKL was expressed 384	  
immediately and abundantly; IE3 was also transcribed with immediate early kinetics, but 385	  
probably less abundantly, and, as expected, the E genes were expressed later (Figure 5B). These 386	  
results suggest that SIINFEKL may have a quantitative and kinetic advantage over IE3 in 387	  
expression during latency. 388	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 389	  
 390	  
 391	  
Discussion 392	  
We have shown that a GFP-SIINFEKL fusion construct, when inserted into MCMV under 393	  
immediate early control, completely dominates the inflationary memory response during chronic 394	  
infection with this virus. The number of SIINFEKL-specific T cells available prior to infection 395	  
was not the main determinant of immunodominance since the SIINFEKL response was still 396	  
dominant in mice expressing SIINFEKL as a self-antigen or after specific peptide tolerization. 397	  
Conversely, adoptive transfer to increase the number of T cells specific for endogenous MCMV-398	  
derived peptides did not enable them to inflate in response to the SIINFEKL-expressing virus. 399	  
However, when mice were co-infected with WT MCMV and our recombinant MCMV 400	  
expressing SIINFEKL, inflationary responses developed to both SIINFEKL and endogenous 401	  
MCMV epitopes. This indicated that when different cells in the same animal were infected with 402	  
each of the individual viruses, and thus WT-infected APCs were able to present MCMV epitopes 403	  
without the competing influence of SIINFEKL, T cells recognizing these epitopes were able to 404	  
inflate alongside the SIINFEKL response.  Yet, when both sets of epitopes were encoded by the 405	  
same virus and presumably expressed on the same APC, T cells responding to SIINFEKL 406	  
outcompeted the MCMV-specific responses. This happened either because these cells had more 407	  
antigen available to them or because they were better able to access antigen. Thus, competition 408	  
for - or availability of - antigen at the level of the APC plays a significant role in the selection of 409	  
inflationary responses during chronic MCMV infection.  410	  
 411	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This competition may be won by the SIINFEKL response, at least in part, because patrolling 412	  
SIINFEKL-specific CD8+ T cells see antigen first and go on to terminate further gene 413	  
transcription. The silencing/desilencing and immune sensing hypothesis proposed by Simon et. 414	  
al. suggests that T-cells specific for the IE1-derived epitope in Balb/c mice prevent further 415	  
MCMV gene transcription. Consistent with this, only IE1 and IE2 transcripts have been found in 416	  
latently-infected lung tissue from Balb/c mice (8). IE3 and gB were found at low levels only 417	  
when the IE1 epitope was mutated such that it could no longer be presented to T-cells (9).  418	  
 419	  
Indeed, the context of MCMV gene expression has been shown to influence whether or not an 420	  
epitope generates an inflationary response. Dekhtiarenko et. al. infect mice with one of two  421	  
recombinant viruses expressing the gB epitope from HSV-1, linked to the carboxy terminus of 422	  
either IE2 or M45. Inflating gB responses are seen only when expression is controlled by the IE2 423	  
promoter. When gB is linked to M45, an E gene, gB T-cell responses dominate only during acute 424	  
infection (31). By eliminating the confounding effects of intrinsic, epitope-specific properties, 425	  
this study lends support to the idea that ordered, temporal viral gene transcription results in 426	  
immune silencing of downstream transcription and subsequent bias of the T-cell response toward 427	  
IE antigens.  428	  
 429	  
A similar scenario is likely at play in our system, where the IE2 promoter controls SIINFEKL 430	  
expression. In addition, SIINFEKL may be more abundant than other MCMV epitopes as a result 431	  
of higher MHC affinity and greater transcription levels. However, in both the BALB/c model and 432	  
the C57BL/6 model, inflationary memory consists of responses to E-encoded antigens as well as 433	  
IE-encoded antigens. This could be explained by the idea that these responses are programmed to 434	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inflate from the time of acute infection, or by the idea that E epitopes are presented by a different 435	  
cell type during latency, one that is undergoing a different program of viral gene expression. 436	  
However, our data argue against both of these ideas. Inflationary responses are not programmed 437	  
early during infection, as MCMV-specific T cells transferred 7 days after infection did not inflate 438	  
in a host later infected with MCMV-GFP-SL8. Thus, repeated antigen exposure after priming is 439	  
a necessary driver of inflationary memory. In addition, different and simultaneous gene 440	  
expression programs are likely not the cause of E-gene-specific inflationary memory, as IE and E 441	  
responses were equally silenced by the expression of SIINFEKL under the IE2 promoter. Thus, 442	  
we favor the hypothesis that competition between T-cell clones for antigen at the level of the 443	  
infected APC dictates the selection of epitopes that drive memory inflation. This hypothesis 444	  
implies that, after WT MCMV infection, IE1-specific T cells (in Balb/c mice) and IE3-specific T 445	  
cells (in B6 mice) fail to completely silence MCMV E-gene expression. 446	  
 447	  
When considering the use of MCMV and eventually HCMV as a vaccine vector, these results 448	  
emphasize the importance of gene expression kinetics and epitope availability in determining the 449	  
size of inflationary memory responses to individual antigens.  450	  
 451	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Figure Legends: 556	  
 557	  
Figure 1: SL8 is profoundly immunodominant over normal responses to MCMV. (A) C57BL/6 558	  
mice were infected i.p with the indicated MCMV viruses. Virus-specific T-cells were measured in 559	  
the blood at the indicated times post infection using intracellular cytokine staining. (B) Individual 560	  
responses from the two infections in part A are contrasted at week 18 post infection. (C) Mice were 561	  
infected with ΔgL-MCMV and CD8 T-cell responses to the indicated epitopes were measured at 562	  
Week 12 post infection using intracellular cytokine staining. Individual plot points and bars represent 563	  
4-5 mice per group. Experiments were done twice.  564	  
 565	  
Figure 2: Phenotype of SIINFEKL-specific and MCMV epitope-specific responses in chronic 566	  
infection. (A) Splenocytes from mice infected for greater than 18 weeks with the indicated viruses 567	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were stained with SL8 or MCMV-specific tetramers and for the indicated surface markers. The plots 568	  
shown are gated on Tetramer+ CD8+ cells (black line) or Tetramer- CD8+ cells (shaded histogram). 569	  
Plots represent one mouse, which is representative of two experiments with 3-4 mice per group. (B) 570	  
Averages of the percent KLRG1 positive, percent CD27 positive, or CD127 mean fluorescence 571	  
intensity of tetramer positive and tetramer negative populations from the splenocytes collected in part 572	  
A. Individual bars represent 3-4 mice per group. Experiment was done twice.  573	  
 574	  
Figure 3: Precursor frequency does not contribute significantly to the immunodominance of 575	  
SIINFEKL-specific CD8 T-cell responses in chronic infection. (A) OVA Tg mice were infected 576	  
i.p. with the indicated viruses. Virus-specific CD8 T-cells were measured in the blood on day 7 and at 577	  
week 18 post infection using intracellular cytokine staining. (B) C57BL/6 mice were injected with 578	  
10µg SIINFEKL peptide i.v. on days -3,-2 and -1 prior to infection with MCMV-GFP-SL8. 579	  
Responses were measured in the blood on day 7 and at week 18 post infection (C) CD45.2+, 580	  
CD45.1+ naive recipients received 2-5x107 unfractionated splenocytes from mice infected for 7 days 581	  
with WT MCMV. Recipients were infected with WT MCMV or with MCMV-GFP-SL8 and virus -582	  
specific responses were measured in the blood at week 18 post infection. Total CD8 T-cell responses 583	  
are shown on the left and percentages of CD45.2-negative donor cells contributing to either IE3 or 584	  
M38 responses are shown on the right. Bars represent 4-5 mice per group. Experiments were done 585	  
twice. 586	  
 587	  
Figure 4: Competition for antigen shapes immunodominance during chronic MCMV infection. 588	  
(A) C57BL/6 mice were infected i.p with WT MCMV and MCMV-GFP-SIINFEKL at the same 589	  
time. Virus-specific T-cells were measured in the blood at the indicated times post infection using 590	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intracellular cytokine staining (B) Mice were infected i.p. with ΔgL MCMV or both ΔgL MCMV 591	  
and MCMV-GFP-SIINFEKL. Virus-specific CD8 T-cell responses were measured in the blood at 592	  
the indicated times post infection. The graph on the left shows the T cell responses at the indicated 593	  
weeks after co-infection. The graph on the right shows the data from all groups at week 18. 594	  
Individual bars represent 4-5 mice per group. Experiments were done twice. 595	  
 596	  
Figure 5: MHC binding affinity of MCMV epitopes and kinetics of expression (A) RMA-S cells 597	  
were incubated with the indicated concentrations of peptide for 2hrs at 25°C and an additional 2hrs at 598	  
37°C, then washed and stained for H2-Kb expression. Experiment was done twice. Shown is the 599	  
normalized mean fluorescence intensity of class I MHC on the surface of cells. (B) Murine 600	  
embryonic fibroblasts were infected with the indicated viruses and RNA was harvested at the time 601	  
points listed on the y-axis. cDNA was made in parallel with no reverse-transcriptase controls for each 602	  
sample, and qRT-PCR was done for the indicated gene products. No signal was obtained from the no 603	  
reverse transcriptase controls. Experiment was done twice.  604	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